PAF1 and pachyonychia congenita: Interestingly, verteporfin treatment (2 μM; 48 h) also inhibited the protein expression levels of PAF1, YAP1, TEAD4, CD133, and SOX9 in KC and PC cells (Fig. 4F–H).